FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

108967001: Sargramostim (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
173502011 Sargramostim en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
606717017 Sargramostim (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
839431000172113 sargramostim fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sargramostim Is a Product containing colony stimulating factor (product) false Inferred relationship Some
Sargramostim Is a Colony stimulating factor (substance) false Inferred relationship Some
Sargramostim Is a Immunomodulator false Inferred relationship Some
Sargramostim Is a Recombinant human granulocyte macrophage colony stimulating factor (substance) true Inferred relationship Some
Sargramostim This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that modifies the immune response or the functioning of the immune system. true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Sargramostim 250mcg injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sargramostim Inferred relationship Some
Sargramostim 500mcg/mL liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sargramostim Inferred relationship Some
Product containing sargramostim (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sargramostim Inferred relationship Some 1
Product containing precisely sargramostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sargramostim Inferred relationship Some
Product containing precisely sargramostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sargramostim Inferred relationship Some 1
Product containing precisely sargramostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sargramostim Inferred relationship Some 1
Product containing sargramostim in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sargramostim Inferred relationship Some 1
Sargramostim only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sargramostim Inferred relationship Some 1
Product containing only sargramostim in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sargramostim Inferred relationship Some 1

This concept is not in any reference sets

Back to Start